Pharmaceutical companies have been announcing deals at breakneck speeds this year in what analysts say is an attempt to hedge risk and hike profits.
Amgen's first-quarter profit dropped 25% amid lower-than-expected sales for the biopharmaceutical firm.
Billionaire activist investor William Ackman said today that the way he accumulated his stake in Botox-maker Allergan was above the board and did not violate insider-trading laws.
Wednesday at 5p ET: He’s making bank and keeping everyone happy. How the 7-year old creator of “Happy Blankie” is giving back to kids!
Wednesday at 8p ET: Why the next move from the revived Tea Party should have Dems worried! Dick Armey joins Cavuto!